Description :
K-7174, one of proteasome inhibitory homopiperazine derivatives, exhibits a therapeutic effect, which is stronger when administered orally than intravenously, without obvious side effects in a murine myeloma model. Moreover, K-7174 kills bortezomib-resistant myeloma cells carrying a β5-subunit mutation in vivo and primary cells from a patient resistant to bortezomib.
Molecular Weight :641.67
Purity :> 98%
Molecular Formula :
C33H50Cl2N2O6
Canonical SMILES :
K-7174
+1 additional providers that we know from the past